Show simple item record

dc.contributor.authorZaidi, Sayyed K.
dc.contributor.authorDowdy, Christopher R.
dc.contributor.authorVan Wijnen, Andre J.
dc.contributor.authorLian, Jane B.
dc.contributor.authorRaza, Azra
dc.contributor.authorStein, Janet L.
dc.contributor.authorCroce, Carlo M.
dc.contributor.authorStein, Gary S.
dc.date2022-08-11T08:08:04.000
dc.date.accessioned2022-08-23T15:41:12Z
dc.date.available2022-08-23T15:41:12Z
dc.date.issued2009-10-15
dc.date.submitted2009-11-04
dc.identifier.citationCancer Res. 2009 Nov 1;69(21):8249-55. Epub 2009 Oct 13. <a href="http://dx.doi.org/10.1158/0008-5472.CAN-09-1567">Link to article on publisher's site</a>
dc.identifier.issn1538-7445 (Electronic)
dc.identifier.doi10.1158/0008-5472.CAN-09-1567
dc.identifier.pmid19826043
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26580
dc.description.abstractDisruption of Runx1/AML1 subnuclear localization, either by a single amino acid substitution or by a chromosomal translocation [e.g., t(8;21)], is linked to the etiology of acute myeloid leukemia (AML). Here, we show that this defect induces a select set of micro-RNAs (miR) in myeloid progenitor cells and AML patients with t(8;21). Both Runx1 and the t(8;21)-encoded AML1-ETO occupy the miR-24-23-27 locus and reciprocally control miR-24 transcription. miR-24 directly downregulates mitogen-activated protein kinase (MAPK) phosphatase-7 and enhances phosphorylation of both c-jun-NH(2)-kinase and p38 kinases. Expression of miR-24 stimulates myeloid cell growth, renders proliferation independent of interleukin-3, and blocks granulocytic differentiation. Thus, compromised Runx1 function induces a miR-dependent mechanism that, through MAPK signaling, enhances myeloid proliferation but blocks differentiation--key steps that contribute to leukemia.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=19826043&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1158/0008-5472.CAN-09-1567
dc.subjectCell Proliferation
dc.subjectCell Differentiation
dc.subjectLeukemia, Myeloid, Acute
dc.subjectCore Binding Factor Alpha 2 Subunit
dc.subjectHumans
dc.subjectMicroRNAs
dc.subjectTranscription Factors
dc.subjectMitogen-Activated Protein Kinase Phosphatases
dc.subjectCell Biology
dc.titleAltered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network
dc.typeJournal Article
dc.source.journaltitleCancer research
dc.source.volume69
dc.source.issue21
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cellbiology_pp/87
dc.identifier.contextkey1055016
html.description.abstract<p>Disruption of Runx1/AML1 subnuclear localization, either by a single amino acid substitution or by a chromosomal translocation [e.g., t(8;21)], is linked to the etiology of acute myeloid leukemia (AML). Here, we show that this defect induces a select set of micro-RNAs (miR) in myeloid progenitor cells and AML patients with t(8;21). Both Runx1 and the t(8;21)-encoded AML1-ETO occupy the miR-24-23-27 locus and reciprocally control miR-24 transcription. miR-24 directly downregulates mitogen-activated protein kinase (MAPK) phosphatase-7 and enhances phosphorylation of both c-jun-NH(2)-kinase and p38 kinases. Expression of miR-24 stimulates myeloid cell growth, renders proliferation independent of interleukin-3, and blocks granulocytic differentiation. Thus, compromised Runx1 function induces a miR-dependent mechanism that, through MAPK signaling, enhances myeloid proliferation but blocks differentiation--key steps that contribute to leukemia.</p>
dc.identifier.submissionpathcellbiology_pp/87
dc.contributor.departmentDepartment of Cell Biology
dc.source.pages8249-55


This item appears in the following Collection(s)

Show simple item record